What is NicoDerm?
NicoDerm (by J&J) and NicoDerm CQ (by GSK) (the CQ is short for Committed Quitters) are brands of nicotine replacement products. Nicotine Patches are a popular Nicotine Replacement Therapy (NRT) and can greatly assist in smoking cessation programs. A Nicoderm or NicoDerm CQ nicotine patch is a transdermal patch that releases nicotine into the body through the skin. Nicotine patches were originally available in the U.S. by prescription only and could only be purchased over-the-counter from 1996.
Nicotine Patches are marketed under several brand names and by several pharmaceutical companies.
NicoDerm® CQ™ patches were introduced by Marion Merrell Dow in November 1991. Manufactured by Alza Corporation (now part of by Johnson & Johnson) they are marketed in the USA by GlaxoSmithKline (GSK). In other countries it is marketed by Johnson & Johnson (formerly Pfizer).
NicoDerm and NicoDerm CQ patches provide a steady and constant controlled dose of nicotine throughout the day. They reduce the effects of nicotine withdrawal. Patches are available in three strengths (commonly 21mg, 14mg and 7mg) and the strength of the patch is reduced over time.